FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008795703> ?p ?o ?g. }

• W2008795703 endingPage "36" @default.
• W2008795703 startingPage "29" @default.
• W2008795703 abstract "We studied the involvement of interferon-regulated, PKR on 2-ME-mediated actions in human osteosarcoma cells. Our results show that PKR is activated by 2-ME treatment and is necessary for 2-ME-mediated induction of osteosarcoma cell death.Osteosarcoma is the most common primary bone tumor and most frequently develops during adolescence. 2-Methoxyestradiol (2-ME), a metabolite of 17beta-estradiol, induces interferon gene expression and apoptosis in human osteosarcoma cells. In this report, we studied the role of interferon-regulated double-stranded (ds)RNA-dependent protein kinase (PKR) protein on 2-ME-mediated cell death in human osteosarcoma cells.Western blot analyses were used to measure PKR protein and phosphorylation levels. Cell survival and apoptosis assays were measured using trypan blue exclusion and Hoechst dye methods, respectively. A transient transfection protocol was used to express the dominant negative PKR mutants.PKR was increased in 2-ME-treated MG63 cells, whereas 17beta-estradiol, 4-hydroxyestradiol, and 16alpha-hydroxyestradiol, which do not induce cell death, had no effect on PKR protein levels. Also, 2-ME treatment induced PKR kinase activity as indicated by increased autophosphorylation and phosphorylation of the endogenous substrate, eukaryotic initiation factor (eIF)-2alpha. dsRNA poly (I).poly (C), an activator of PKR protein, increased cell death when osteosarcoma cells were treated with a submaximal concentration of 2-ME. In contrast, a serine-threonine kinase inhibitor SB203580 and a specific PKR inhibitor 2-aminopurine (2-AP) blocked the 2-ME-induced cell death in MG63 cells. A dominant negative PKR mutant protein conferred resistance to 2-ME-induced cell death to MG63 osteosarcoma and 2-ME-mediated PKR regulation did not require interferon gene expression. PKR protein is activated in cell free extracts by 2-ME treatment, resulting in autophosphorylation and in the phosphorylation of the substrate eIF-2alpha. We conclude from these results that PKR is regulated by 2-ME independently of interferon and is essential for 2-ME-mediated cell death in MG63 osteosarcoma cells." @default.
• W2008795703 created "2016-06-24" @default.
• W2008795703 creator A5007299404 @default.
• W2008795703 creator A5016934014 @default.
• W2008795703 creator A5042158105 @default.
• W2008795703 creator A5063505576 @default.
• W2008795703 date "2007-01-01" @default.
• W2008795703 modified "2023-10-11" @default.
• W2008795703 title "Double-Stranded RNA-Dependent Protein Kinase Is Involved in 2-Methoxyestradiol-Mediated Cell Death of Osteosarcoma Cells" @default.
• W2008795703 cites W105324358 @default.
• W2008795703 cites W1548741427 @default.
• W2008795703 cites W1582095946 @default.
• W2008795703 cites W1597060371 @default.
• W2008795703 cites W1598262791 @default.
• W2008795703 cites W1765450442 @default.
• W2008795703 cites W1821095830 @default.
• W2008795703 cites W1903239102 @default.
• W2008795703 cites W1968987342 @default.
• W2008795703 cites W1970812281 @default.
• W2008795703 cites W1971831859 @default.
• W2008795703 cites W1978340521 @default.
• W2008795703 cites W1981945864 @default.
• W2008795703 cites W1983859259 @default.
• W2008795703 cites W1988981229 @default.
• W2008795703 cites W1990549640 @default.
• W2008795703 cites W1992583586 @default.
• W2008795703 cites W1998948981 @default.
• W2008795703 cites W1999592964 @default.
• W2008795703 cites W2010358674 @default.
• W2008795703 cites W2013351020 @default.
• W2008795703 cites W2015686762 @default.
• W2008795703 cites W2022969546 @default.
• W2008795703 cites W2025888779 @default.
• W2008795703 cites W2027872174 @default.
• W2008795703 cites W2032884648 @default.
• W2008795703 cites W2034426069 @default.
• W2008795703 cites W2039907166 @default.
• W2008795703 cites W2042772639 @default.
• W2008795703 cites W2047391267 @default.
• W2008795703 cites W2055639096 @default.
• W2008795703 cites W2060511918 @default.
• W2008795703 cites W2062417484 @default.
• W2008795703 cites W2080133175 @default.
• W2008795703 cites W2081514938 @default.
• W2008795703 cites W2084312950 @default.
• W2008795703 cites W2086619832 @default.
• W2008795703 cites W2089033636 @default.
• W2008795703 cites W2092841570 @default.
• W2008795703 cites W2098440166 @default.
• W2008795703 cites W2103565638 @default.
• W2008795703 cites W2107410297 @default.
• W2008795703 cites W2116648773 @default.
• W2008795703 cites W2123731765 @default.
• W2008795703 cites W2130104095 @default.
• W2008795703 cites W2130684922 @default.
• W2008795703 cites W2151484003 @default.
• W2008795703 cites W2157894908 @default.
• W2008795703 cites W2163476769 @default.
• W2008795703 cites W2166497605 @default.
• W2008795703 cites W2181372246 @default.
• W2008795703 cites W2329253721 @default.
• W2008795703 cites W2330248224 @default.
• W2008795703 cites W2332678957 @default.
• W2008795703 cites W2404021914 @default.
• W2008795703 cites W35792596 @default.
• W2008795703 cites W65867874 @default.
• W2008795703 doi "https://doi.org/10.1359/jbmr.060914" @default.
• W2008795703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1955766" @default.
• W2008795703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17014383" @default.
• W2008795703 hasPublicationYear "2007" @default.
• W2008795703 type Work @default.
• W2008795703 sameAs 2008795703 @default.
• W2008795703 citedByCount "16" @default.
• W2008795703 countsByYear W20087957032012 @default.
• W2008795703 countsByYear W20087957032013 @default.
• W2008795703 countsByYear W20087957032015 @default.
• W2008795703 countsByYear W20087957032016 @default.
• W2008795703 countsByYear W20087957032017 @default.
• W2008795703 countsByYear W20087957032018 @default.
• W2008795703 countsByYear W20087957032021 @default.
• W2008795703 crossrefType "journal-article" @default.
• W2008795703 hasAuthorship W2008795703A5007299404 @default.
• W2008795703 hasAuthorship W2008795703A5016934014 @default.
• W2008795703 hasAuthorship W2008795703A5042158105 @default.
• W2008795703 hasAuthorship W2008795703A5063505576 @default.
• W2008795703 hasBestOaLocation W20087957031 @default.
• W2008795703 hasConcept C150109051 @default.
• W2008795703 hasConcept C153911025 @default.
• W2008795703 hasConcept C161238802 @default.
• W2008795703 hasConcept C184235292 @default.
• W2008795703 hasConcept C190283241 @default.
• W2008795703 hasConcept C203014093 @default.
• W2008795703 hasConcept C2776178377 @default.
• W2008795703 hasConcept C29537977 @default.
• W2008795703 hasConcept C31573885 @default.
• W2008795703 hasConcept C502942594 @default.
• W2008795703 hasConcept C54009773 @default.
• W2008795703 hasConcept C54355233 @default.

• next